Lilly, J&J and AbbVie Hit New Highs
Lilly, Johnson & Johnson and AbbVie stocks reach unprecedented levels as investors shift from tech to healthcare.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Lilly, Johnson & Johnson and AbbVie have reached new highs in stock value. This trend is part of a broader shift in the market where healthcare stocks are gaining traction.
Coverage emphasizes a movement of investors from technology to healthcare. Moomoo, Finimize, Benzinga, Seeking Alpha, WSJ and Yahoo Finance all report on this trend.
Watch for further developments in healthcare stock performance and any additional companies that may see similar gains.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 2h ago.
Quick answers
Which companies are experiencing stock value increases?
Lilly, Johnson & Johnson and AbbVie are the companies mentioned in the coverage.
What is driving the increase in healthcare stocks?
Coverage does not yet specify the reasons behind the shift from tech to healthcare stocks.
Which outlets are reporting on this trend?
Moomoo, Finimize, Benzinga, Seeking Alpha, WSJ and Yahoo Finance are among the outlets covering this trend.
Coverage (6)
- Healthcare Stocks Have Become a Haven for Investors Ditching Tech Moomoo · 1d ago
- Healthcare Stocks Got A Late Lift From Big Headlines Finimize · 1d ago
- 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Benzinga · 1d ago
- Lilly, J&J, AbbVie hit all-time highs as healthcare outperforms Seeking Alpha · 1d ago
- Health Care Roundup: Market Talk WSJ · 1d ago
- Lilly, J&J and AbbVie Hit New Highs Yahoo Finance · 1d ago
Topics
Related trends
Stock Price Prediction: Palantir at $113, The Forecast Says There’s Room to Run
Palantir faces a volatile market as valuation concerns and a 23% year-to-date decline clash with forecasts predicting a rise to $113.
US stocks edge higher as falling oil prices help take pressure off the market
US stocks show modest gains as oil prices drop, easing market pressure.
Sangamo to put ‘substantially all’ assets for sale in bankruptcy, lines up Lilly and Astellas as buyers
Sangamo Therapeutics' bankruptcy filing and asset sale to Lilly and Astellas is making waves in the biotech industry.
Trump may be mystery patient in odd case of 79yo getting experimental obesity drug
Speculation swirls around a 79-year-old patient who received an experimental weight loss drug, with former President Trump as the suspected recipient.
Salesforce Stock Marks a Record 14-Day Losing Streak
Salesforce stock has entered a record 14-day losing streak, plummeting to a 52-week low.
S&P 500 closes lower as tech stocks slide; SpaceX notches 3-day losing streak: Live updates
The S&P 500 and Nasdaq have closed lower as a sell-off in megacap tech and SpaceX impacts the broader market.